NexGel Inc (NXGL)
2.15
+0.05
(+2.38%)
USD |
NASDAQ |
Apr 30, 16:00
2.15
0.00 (0.00%)
After-Hours: 20:00
NexGel Cash from Financing (TTM): 0.379M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.379M |
September 30, 2023 | -0.065M |
June 30, 2023 | -1.632M |
March 31, 2023 | -1.631M |
December 31, 2022 | -3.662M |
September 30, 2022 | 9.659M |
June 30, 2022 | 12.66M |
March 31, 2022 | 12.66M |
December 31, 2021 | 16.34M |
Date | Value |
---|---|
September 30, 2021 | 3.627M |
June 30, 2021 | 2.506M |
March 31, 2021 | 2.914M |
December 31, 2020 | 1.884M |
September 30, 2020 | 1.986M |
June 30, 2020 | 1.758M |
March 31, 2020 | 2.139M |
December 31, 2019 | 2.075M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.662M
Minimum
Dec 2022
16.34M
Maximum
Dec 2021
3.741M
Average
2.075M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Anika Therapeutics Inc | -6.324M |
The Cooper Companies Inc | 116.00M |
Staar Surgical Co | 7.415M |
OrthoPediatrics Corp | 7.301M |
Innovative Eyewear Inc | 6.661M |